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resumo 
 
 
As nanopartículas são definidas como partículas com dimensão entre 1 - 100 
nm, resultando em propriedades únicas que podem ser úteis em diversas 
áreas. As AgNP são as nanopartículas mais utilizadas em produtos comerciais, 
como: curativos, cateteres, próteses, cosméticos, têxteis e produção de 
alimentos, devido à sua atividade antimicrobiana. As propriedades físico-
químicas únicas inerentes às NPs enfatizam a necessidade de uma avaliação 
adequada dos potenciais efeitos tóxicos, já que suas interacções com sistemas 
biológicos, bem como o seu destino ambiental são imprevisíveis. As 
propriedades da superfície das NPs são de importância essencial para a sua 
capacidade de agregação, influenciando na mobilidade e absorção celular. 
Neste estudo, avaliaram-se os efeitos tóxicos de AgNPs não revestidas e 
revestidas, na viabilidade das linhas celulares de osteossarcoma (MG-63) e 
adenocarcinoma do pulmão (A549). Para isso, células cultivadas in vitro foram 
expostas a concentrações crescentes de AgNPs até 400μg/ml (não revestidas 
- <100nm) e até 100ug/ml (revestidas com PVP – 10 e 20nm), durante 24h e 
48h. O crescimento celular e morfologia foram observados diariamente, 
utilizando um microscópio invertido e a viabilidade celular foi medida pelo 
ensaio MTT. Para AgNPs não revestidas (24h e 48h), os ensaios de MTT e 
Trypan Blue, revelam uma disparidade de resultados sendo, ambos 
inconclusivos. No entanto, para as AgNPs revestidas, os ensaios de MTT 
independentes, mostraram resultados consistentes e fiáveis, com uma 
diminuição significativa da viabilidade celular a 50μg/ml. As AgNPs também 
modulam a distribuição do ciclo celular através da acumulação de células em 
G2/M, e concomitante diminuição de células em G0/G1, juntamente com o 
aumento da apoptose. Em conjunto, estes resultados sugerem que AgNPs 
induzem toxicidade, apoptose e paragem do ciclo celular em G2, nas linhas 
celulares A549 e MG-63. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
keywords 
 
Silver Nanoparticles, coated AgNPs, uncoate AgNPs, A549, MG-63, toxicity, 
apoptosis, cell cycle arrest.  
abstract 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Nanoparticles are defined as particles with at least one dimension between 1 – 
100nm and this small size results in unique properties that can be useful in a 
range of fields. Silver nanoparticles (AgNPs) are the most widely used 
nanoparticles in commercial products, viz wound dressings, catheters, 
prosthesis, cosmetics, textiles and food production, due to their antimicrobial 
activity. The unique physicochemical properties of NPs emphasize the need for 
proper assessment of the potential toxic effects, since their unpredicted 
interactions with biological systems and environmental fate. The surface 
properties of NPs are of essential importance for their aggregation behavior, 
and this influences their mobility in environmental partitions and cellular uptake. 
In this study, we evaluated the toxic effects of uncoated and coated AgNP on 
the viability osteosarcoma (MG-63) and lung (A549) cell lines. For this, in vitro 
cultured cells were exposed to different increasing concentrations of AgNPs up 
to 400µg/mL (uncoated - <100nm) and up to 100µg/ml (PVP coated – 10 and 
20nm) for 24h and 48h. Cell growth and morphology was daily observed using 
an inverted microscope and cell viability was measured by MTT reduction 
assay. For uncoated AgNPs (24h and 48h), MTT assays and Trypan Blue and 
reveal a disparity of results being both inconclusive. However, for the coated 
AgNPs, independent MTT assays showed consistent and reliable results, with 
a significant decrease in cell viability at the 50µg/ml. AgNPs also modulated cell 
cycle distribution through the accumulation of cells at G2/M and a concurrent 
decrease in cells at G0/G1 along with the increase on apoptotic cells. This 
effect was observed in both cell lines. Together, these results suggest that 
AgNPs induce toxicity, apoptosis and G2 cell cycle arrest in A549 and MG-63 
cells. 
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1. Introduction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Publications: 
Introduction partially published in an international journal: C. Remédios, F. Rosário, and 
V. Bastos, “Environmental Nanoparticles Interactions with Plants: Morphological, 
Physiological, and Genotoxic Aspects,” Journal of Botany, vol. 2012, Article ID 751686, 8 
pages, 2012. doi:10.1155/2012/751686. 
Research experiment was partially published in international and national congresses. 
Research experiment will be submitted to an international Journal. 
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1.1 Historical Overview 
In 1959, Richard Feynman, an American physicist and Nobel laureate, firstly used 
the concept of nanotechnology, as a title for one of his articles, reporting a lecture 
“There’s plenty room at the bottom”(Maynard et al., 2006). 
The Japanese researcher Professor Norio Taniguchi, in 1974, was the first to define 
the term nanotechnology, reporting “nanotechnology mainly consists of the processing of 
separation, consolidation, and deformation of materials by one atom or by one 
molecule.” Later, in 1980, Dr. K. EricDrexler explored the concept of this emerging field, in 
particular promoting technological significance of nanoscale phenomena and devices. 
More recently, in 2000, to coordinate federal nanotechnology research and development, 
the United States National Nanotechnology Initiative was founded (e.g., see 
http://www.nano.gov/).  
Nowadays, nanotechnology is a revolutionary science, with predicted evolution 
within the next decades that may have equivalence with the ones observed for other 
industries, as the one of computers during the second half of the last century or earlier 
with the automobile industry (please see 
http://www.nanotechnologyresearchfoundation.org/nanohistory.html).  
This emerging nanoparticles (NPs) industry is expected to contribute to diverse 
products and services and to serve multiple consumers’ purposes.  
However, and despite the success of nanotechnology, the release of NPs to the 
environment remains unknown, mostly due to the lack of scientific knowledge concerning 
the potential health and environmental risks associated with nanomaterials (NMs).  
Despite this, NPs are being considered in the restrict group of emerging 
contaminants by, for example, some European countries (e.g., http://files.nanobio-
raise.org/Downloads/scenihr.pdf) and the United States Environmental Protection Agency 
(EPA) (e.g., http://www.epa.gov/fedfac/pdf/emerging_contaminants_nanomaterials.pdf). 
 
1.2 Nanoparticles Description 
The unit nanometer was derived from the Greek “nano” which means “dwarf,” 
since nanometers are referred to particles smaller than 1000nm or 1 μm (Buzea et al., 
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2007). However, NMs have been considered to be substances with a dimension less than 
100nm (Farré et al., 2011; Nowack and Bucheli, 2007; Walker and Bucher, 2009). NPs, 
considered the building blocks of nanotechnology (Stern and McNeil, 2008), have at least 
one dimension at 100nm or less, which provides a high surface/volume ratio, leading to 
high reactivity (increasing the potential to cross cell membranes) (Farré et al., 2011) or 
intrinsic toxicity of the surface (Das and Ansari, 2009; Donaldson et al., 2004). These 
factors act together and can change or enhance properties of NPs, such as strength, 
electrical properties, and optical characteristics (Farré et al., 2011).  
 
1.3 Nanoparticles Classification 
The main important thing in nano dimension is that the properties of particles are 
far different than bulk scale properties and besides, their small size and large surface area 
can´t determine the harmful potential of NPs (Donaldson et al., 2006). NPs can be 
classified regarding to their dimensionality, morphology, composition, uniformity, and 
agglomeration (Buzea et al., 2007), since they can be spherical, tubular, irregularly shaped 
and can also exist in fused, aggregated or agglomerated forms. Dimensionality refers to 
their shape or morphology, which can classify them on their number of dimensions, such 
as one-dimensional (1D), two-dimensional (2D), three-dimensional (3D) NMs (Nowack 
and Bucheli 2007. The characteristics to be taken relatively to NPs morphology are 
flatness, sphericity, and aspect ratio. NPs can be composed of single or several materials; 
composites of various agglomerated materials can be found in nature, although single 
composites can be easily synthesized today. In respect to uniformity and agglomeration, 
NPs can exist as dispersed aerosols, suspensions/colloids, or in agglomerate state, due to 
their different chemistry and electromagnetic properties. Despite some diverse 
classifications of NPs that can be found, one can in general divide the following classes 
according to their composition (e.g., (EPA. 2007)): 
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(1) carbon-based materials (e.g., C60 fullerene), with particular potential in 
carbon nanotubes technology, 
(2) metal-based substances (e.g., Ag, Au, and nanometal oxides), among the 
last ones, for example, those of titanium oxide are of particular interest, 
(3) dendrimers, polymers consisting of branched units, 
(4) bio-inorganic complexes (e.g., titanium with attached DNA strands) (EPA. 
2007). 
 
1.4 Nanoparticles Sources 
NPs can be derived from natural and anthropogenic sources (engineered and 
unwanted or incidental NPs) (Biswas and Wu, 2005; Liden, 2011; Walker and Bucher, 
2009). The natural processes that produce NPs can be photochemical reactions, volcanic 
eruptions, forest fires, simple erosion, and by plants and animals (shedding of skin and 
hair) (Buzea et al., 2007). Otherwise, anthropogenic sources refer to the following: 
(1) engineered NMs classified as carbon NMs, metal oxide NPs, zero-valence 
metal NPs, quantum dots (QDs) and dendrimers (Farré et al., 2011), 
(2) unwanted or incidental NPs from by-products of simple combustion, food 
cooking, and chemical manufacturing; welding or refining and smelting; combustion in 
vehicle and airplane engines; combustion of treated pulverized sewage sludge; and 
combustion of coal and fuel oil for power generation. 
 
From their multiple conformation, composition, and nature, NPs present multiple 
functions and almost infinite applications. Nanotechnology has, therefore, gained a place 
as an emerging science with a recent rise in interest of NPs, mostly due to our increasing 
ability to synthesize and manipulate such particles. 
Thus, nanoscale materials have a variety of uses in different areas, such as 
electronic, biomedical, pharmaceutical, cosmetic, energy, environmental, catalytic, and 
material applications (Nowack and Bucheli, 2007), as described below. 
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1.5 Nanoparticles applications 
NMs have diverse applications, which can be summarized as follows (Biswas and 
Wu, 2005): sunscreens and cosmetics (nanosized titanium dioxide and zinc oxide in 
sunscreens, nanosized iron oxide in some lipsticks); shampoos and detergents (nanosized 
alumina); window panes and ceramic tiles (nanostructured titanium oxides); 
pharmaceutical products; medical implants; food packaging; biosensors and agents for 
environmental remediation; water treatment technology; composites (mechanical, 
optical, electrical, and magnetic properties); clays (construction materials); coatings and 
surfaces; tougher and harder cutting tools; paints; displays (television screens and 
computer monitors); batteries (growth in portable electronic equipment); fuel additives; 
carbon nanotube composites; lubricants (nanosized “ball bearings”); magnetic materials; 
machinable ceramics; and military battle suits. However, and considering the statement 
that all technology comes with a price, nanotechnology could lead to environmental 
hazards and adverse health effects (Maynard et al., 2006). 
 
1.6 Nanotoxicology  
Primary geogenic NPs may form as aerosols from, for example, sprays of salts and 
sulfates mostly from the sea, or as sulfate aerosols from volcanic emissions, or even as 
forest fires (soot and/or polycyclic aromatic hydrocarbons). Moreover, NPs may be 
anthropogenically introduced in the environment, for example, intentionally to remediate 
groundwater and contaminated soil (Flahaut, 2010; Klaine et al., 2008), or also 
unintentionally by several sources, as research and clinical settings and solid or liquid 
waste streams production facilities (Ray et al., 2009). The biggest risk of release of this 
material may occur during transportation to good manufacturers and by intentional 
releases for environmental application (Flahaut, 2010; Ray et al., 2009). The toxicity and 
degradation of these compounds in the environment cannot be accurately assessed yet 
because it depends on the NPs type, physicochemical properties, and also the 
environment media in which partition and the respective conditions. So, this is a field that 
requires intense research. For example, it is recognized that research needs to be 
performed in the following fields: (a) detection of NPs in the environment, (b) 
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measurement of emissions of NPs, (c) life-cycle of NPs in the environment, (d) toxicity of 
NPs to the environment, and (e) immediate and longer impact on environment (e.g., 
http://www.nanocap.eu/). The concern of NPs exposure is due to some important issues, 
as these materials half-lives that may be months to possibly years, the increase on 
concentration of anthropic substances since NPs are often produced in a large scale, and 
because this material is expected to be accumulated and transformed by time and local 
environmental conditions (Flahaut, 2010; Hardman, 2006). The current knowledge about 
NPs and the challenges of nanotoxicity assessment lead to a lack of effective regulation of 
NPs use. Some governmental entities, as EPA, have been conducting efforts in order to 
not only comprehend the properties of NPs and their potential risks for human health and 
the environment but also to regulate the use, storage, and disposal of these materials to 
allow a safe and sustainable nanotechnology development. Although there are no specific 
environmental laws, NPs cut across some existing EPA regulations. For example, several 
NMs are considered chemical substances under the Toxic Substances Control Act, and 
pesticides containing nanotechnology products are regulated under the Federal 
Insecticide, Fungicide, and Rodenticide Act (see http://www.epa.gov/nanoscience/). Still, 
a recent report from EPA’s Office of Inspector General stated that “. . . EPA does not 
currently have sufficient information or processes to effectively manage the human 
health and environmental risks of nanomaterials. . .” and that “. . . EPA has the statutory 
authority to regulate nanomaterials but currently lacks the environmental and human 
health exposure and toxicological data to do so effectively” (U.S. EPA, 2011). According to 
this report, some proposed policies have failed, and others that await approval are facing 
significant barriers to their effectiveness (U.S. EPA, 2011). 
 
1.7 Silver Nanoparticles  
Silver Nanoparticles (AgNPs) are one of the promising products in the 
nanotechnology industry. AgNPs can be synthesized by several physical, chemical and 
biological methods from metallic silver, and their specific physicochemical properties may 
differ from those of the bulk substance or from particles of larger size. This effect is 
mainly attributed to high surface area to volume ratio, which potentially results in high 
 15 
 
reactivity. The development of consistent processes for the synthesis of silver 
nanomaterials is an important aspect of current nanotechnology research. 
From the 1300 NP-containing commercial products, that are recently available on 
the market, at least 300 products (∼25%) contain AgNPs (Rejeski, 2011)). Besides allowing 
more vigorous reactions due to increase in surface area/volume ratio (leading to high 
reactivity or intrinsic toxicity of the surface), another advantage is that AgNPs has a great 
antimicrobial activity, being used in, wound dressings, clothing, laundry detergents, room 
sprays, food, catheters, surgery instruments and bone cement  (Asharani et al., 2009a; 
Chaloupka et al., 2010). 
AgNPs are mostly smaller than 100 nm, and consist of about 20-15,000 silver 
atoms and the small size enables the passage through biological membranes (Oberdorster 
et al., 2005). Different shapes and sizes of AgNP, have been shown to bind and react with 
proteins, be phagocytosed by immune cells, deposited in tissue, or translocate to other 
parts of the body, leading to a variety of tissue responses (e.g. generation of reactive 
oxygen species (ROS), inflammation and cell death). Recent studies reported that AgNPs, 
reduce mitochondrial activity and increase ROS, deplete antioxidant GSH content 
(Ahamed et al., 2008; AshaRani et al., 2009b; Beer et al., 2012; Biswas and Wu, 2005; 
Donaldson et al., 2004; Foldbjerg et al., 2011).  
Despite of the wide use of AgNPs, there is no data about their concentration, size 
or form in which they are present in commercially products. Neither on the amount Ag 
released. Although concentrations of bioavailable free silver ions, in the natural 
environment in general are too low to lead to toxicity, it is not known until now whether 
AgNPs present a threat to the environment.  
These NPs, showed to have different interactions with several organisms like, 
bacteria, virus, daphnia, plants and rats (Allen et al., 2010; Remédios et al., 2012; 
Semmler et al., 2004).  
Though, one of the good examples of positive vs negative effects is the extensively 
use of AgNP as antimicrobial agent against pathogenic bacteria. The abusive use is leading 
to negative consequences, against the populations of soil microbes that play beneficial 
roles in the environment, such as promoting plant growth, element cycling, and 
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degradation of pollutants. The NPs of Ag, showed both toxicity on pathogenic bacteria 
(e.g., Escherichia coli and Staphylococcus aureus) and beneficial effects on microbes, as 
Pseudomonas putida, which has bioremediation potential and is a strong root colonizer 
(Molina et al., 2006; Ramos-Gonzalez et al., 2005).  
 
1.8 Toxicity assessment - Techniques and Biomarkers 
The use of AgNPs has increased along the years, and since these NPs are widely 
used there is few information on the AgNPs interaction with human organs, tissues and 
cells, regarding the health implications, occupational risks and hazards. 
Several in vitro studies have shown that silver NPs can induce toxic effects such as, 
induction of apoptosis, inflammation, DNA-strand breaks, point mutations, and oxidative 
DNA adducts, free radical production and membrane damage (Ahamed et al., 2008; 
AshaRani et al., 2009b; Deng et al., 2010; Foldbjerg et al., 2011; Jun et al., 2011; Lu et al., 
2010). However, due to their characteristics, the real toxicity of NPs can be difficult to 
assess, as there are a number of factors that can interfere, as: the influence of NPs with 
toxicity assays. The release of silver ions by nanoparticles, particle dissolution, 
agglomeration, shape, size and type of surface coating are important characteristics that 
could induce to wrong results over/underestimating the real toxicity of NPs (Bae et al., 
2010; El Badawy et al., 2012; Kittler et al., 2010; Liu et al., 2010a; Wijnhoven et al., 2009). 
In vitro studies are a fastest, less expensive and less ethically ambiguous way to 
evaluate the toxicity, of a wide range of compounds. Respecting the principle of 3R’s 
(Reducement, Refinement and Replacement) it is possible to mimic the in vivo or 
environmental conditions. The control of culture conditions such as, pH, temperature, 
nutrient and waste concentrations, is crucial to ensure that the toxicity it is from the 
compound and not because of unstable culturing conditions. Some of the assays 
mentioned below have been adapted for the use of microplate readers allowing for a 
rapid throughput (Weyermann et al., 2005). 
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1.8.1 Cell proliferation/viability 
1.8.1.1 MTT Assay 
MTT assay described by Mosmann (Mosmann, 1983) has been widely used as a 
colorimetric approach, based on the activity of mitochondrial dehydrogenase enzymes in 
cells. This assay made possible to evaluate viable and proliferating cells. Mithocondrial 
enzymes of viable cells can perform the cleavage of MTT (tetrazolium salt) into a soluble 
formazan product. The resulting intracellular purple formazan can be solubilized and 
quantified by spectrophotometry, and the amount of formazan produced is directly 
proportional to the number of living cells, being widely accepted as a reliable way to 
examine cell proliferation (Mosmann, 1983; Twentyman and Luscombe, 1987). The 
number of assay steps has been minimized to such an extent to fulfill the necessity to 
process large numbers of samples (Mosmann, 1983). The MTT reagent yields low 
background absorbance values, in the absence of cells and for each cell type the linear 
relationship between cell number and signal produced is established, thus allowing an 
accurate quantification of changes in the rate of cell proliferation (Mosmann, 1983). 
Although, MTT test it is a standard test with low background absorbance, interference of 
AgNPs on the redout of light absorption for MTT assay has been described (Kroll et al., 
2009; Sabatini et al., 2007; Samberg et al., 2010) 
 
1.8.1.2 Trypan Blue 
One of the most used criteria’s for characterizing viable from dead cells, is the 
integrity status of the cell membrane, distinguishing cells with damaged or compromised 
s. Live or dead cells could be assessed for example by  the trypan blue (diazo dye) test. 
This test, is based on the fact that intact cell membranes are impermeable to the dye and, 
therefore alive cells exclude trypan blue (also called trypan blue exclusion test), while 
dead cells uptake it, appearing blue under the microscope or when analyzed by the 
automated cell counter TC10TM (Bio-Rad, Hercules, CA)(Gregori et al., 2001). 
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1.8.2 Cell cycle analysis 
Cell cycle analysis and proliferation kinetics are two major factors in toxicological 
studies and tumor progression evaluation. Due to its importance, flow cytometry brought 
the possibility of performing measurements with speed and precision revolutionizing cell 
biology and cell cycle studies. Cell cycle is the biological phenomenon where 
undifferentiated cells originate daughter cells with same genetic characteristics. Cell cycle 
involves interphase and mitosis. There are four distinct phases in a population of 
proliferating cells: growth and preparation of the chromosomes for replication (G1 
phase), synthesis of DNA and duplication of the centrosome (S phase), preparation for 
mitosis (G2 phase) and mitosis (M phase) (Nunez, 2001). To uphold the normal 
progression of the cell cycle and the surveillance of genomic integrity, cells have 
developed a complex network of DNA repair pathways and cell cycle checkpoints. There 
are cell cycle checkpoints at G1-S, at G2-M, at the exit of mitosis, and an S-phase 
checkpoint that detects and responds to DNA damage and replication stress. The 
checkpoints lie in biochemical signaling pathways to sense various types of structural 
defects in DNA, or in chromosome function, and provoke a versatile cellular response that 
activates DNA repair and delays cell-cycle progression. These mechanisms evolved to 
manage inherent errors and genotoxic stress (cellular metabolites or xenobiotics). Hence, 
when DNA damage is severe, checkpoints purge such potentially hazardous cells by cell 
death or induce cell-cycle arrest, to essentially offer the time necessary to repair the 
damage of the DNA before cell division (Koren, 2007; Palou et al., 2010; Soviknes and 
Glover, 2008). 
 
1.8.3 Apoptosis/Necrosis 
Apoptotic and necrotic cell death can be detected by physiological changes that 
occur in the cell. An apoptotic cell externalizes phosphatidylserine (PS) from the inner to 
the outer leaflet of the plasma membrane, as a marker of early apoptosis. While a 
necrotic cell has a damage and inflamed cell membrane that allows the entry of 
propidium iodide (PI). 
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Annexin V is a phospholipid-binding protein (aV) that has a high affinity for PS. The aV 
conjugated to FITC (fluorescein isothiocyanate) binds to PS, staining early-stage apoptotic 
cells that externalize it and it can be accessed by flow cytometry. Late-stage apoptotic and 
necrotic cells can be identified by the binding of PI to nuclear DNA. These cells are stained 
double positive, both for aV+FITC and PI.  
 
 
1.9 MG-63 cell line 
The bone is extensively exposed to NPs, by medical devices, bone cement and 
bone implants. The major challenge of tissue engineering  is to find appropriate materials 
that could control infection and also allow bone regeneration. In the past years, AgNPs 
have been used as supplement, acting like an antimicrobial agent on bone implants and 
bone cement. The most important characteristics of this supplement it is biocompatibility 
and non-toxicity (Alt et al., 2004; Chaloupka et al., 2010; Zheng et al., 2010).  
In this study, we use MG-63 cell line, which is derived from malignant bone tumor 
(human osteosarcoma). These cells, exhibit characteristics from osteoblastic-like cells 
including fibroblast morphology, high levels of alkaline phosphatase activity and 
osteoblast-like regulated synthesis of osteocalcin and collagen type I (Bilbe et al., 1996; 
Pautke et al., 2004). Although, these cells share osteoblastic features, their chromosomal 
alterations lead to abnormal molecular and cellular functions, with multiple tryploidy (Di 
Palma et al., 2003).  
MG-63 is a continuous cell line with infinite growth potential, for a long period of 
time, relatively easy to culture (grows on an adherent monolayer) and has a high rate of 
proliferation. These characteristics made MG-63 cell line suitable for this type of in vitro 
tests.(Di Palma et al., 2003).  
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1.10 A549 cell line 
Since the increase in the industrial production of manufactured nanoparticles, the 
general population may be extremely more exposed to these particles present in the air. 
Therefore, the most common and important route of exposure to AgNPs is via 
occupational inhalation, of airborne particles, possible leading to negative pulmonary 
effects (Oberdorster et al., 2002; Semmler et al., 2004).   
Lung cancer remains the most common type of cancer, in men and women 
worldwide, and the most common cause of cancer mortality (Jaramillo et al., 2008; Zhao 
et al., 2005). The most common lung cancers are called carcinomas and arise from 
epithelial cells. Lung carcinomas can be divided in two main types – small cell lung 
carcinoma (SCLC) and non-small cell lung carcinoma (NSCLC) – according to their size an 
appearance. NSCLC can also be divided into three main sub-types - adenocarcinoma (40% 
of lung cancer and the most common type on non-smokers), squamous-cell lung 
carcinoma, and large-cell lung carcinoma (Vincent et al., 1977; Zhao et al., 2005).  
A549 cells derived from human lung adenocarcinoma, and it has been well-
characterized and widely used in in vitro toxicity tests (Foster et al., 1998; Lieber et al., 
1976). These cells, are quite important since they are responsible for the diffusion of 
some substances, (e.g. water and electrolytes) across the alveoli. When culture in vitro, 
these cells are grow as an adherent monolayer, and show multilamellar cytoplasmic 
inclusions bodies, that are typical from type II alveolar epithelial cells of the lung. 
Furthermore, these cells, synthetize lecithin (act as a surfactant) with high percentage of 
disaturated fatty acids (Jaramillo et al., 2008; Lieber et al., 1976). Altogether, A549 cells are 
suitable to serve as an in vitro model of human adenocarcinoma cells (Lieber et al., 1976). 
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1.11 Aims 
The aim of the present dissertation, it was to evaluate the toxic effects of AgNPs 
on bone and lung cells.  
The osteosarcoma cell line MG-63, has rapid growth and retains most osteoblast 
like characteristics (Clover and Gowen, 1994) was chosen as model of bone. The human 
alveolar basal epithelial cell line A549, was chosen as model of lung.  Being the lung the 
main portal entry of inhaled NPs and bone extensively exposed to NPs by medical devices, 
bone cement and bone implants, both are suitable to serve as model for this study.  
These cells were exposed to increasing concentrations of, both uncoated and 
coated NPs (different surface properties), and cell viability, cell cycle and apoptosis were 
evaluated. 
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2. Material and Methods  
2.1 Mg-63 osteoblast cell line culture 
Mg-63 cell line was cultured in 75 cm2 (Corning®) culture flasks with 10ml of α-
MEM – Minimum Essential Medium (Gibco) supplemented with 10% (v/v) Fetal Bovine 
Serum (FBS) (Gibco), 10000 units ml-1 of penicillin-streptomycin (Gibco) and 2.5 μg/ml of 
Fungizone (Gibco).  
The cell line was maintained at controlled humid atmosphere at 37 °C and 5% CO2. 
Cells were routinely observed under microscope to check confluence, contaminations and 
morphology. Before cells reach approximately 80% confluence (% of cell coverage on the 
surface area of the culture vessel), they were subcultured.  
 
2.2 A549 Human alveolar adenocarcinoma cell line culture 
The A549 cell line was cultured in 75 cm2 (Corning®) culture flasks with 10ml of 
Kaighn's Modification of Ham's F-12 Medium (F-12K) supplemented with 10% (v/v) Fetal 
Bovine Serum (FBS) (Gibco), 10000 units ml-1of penicillin-streptomycin (Gibco) and 2.5 
μg/ml of Fungizone (Gibco).  
The cell line was maintained at controlled humid atmosphere at 37 °C and 5% CO2. 
Cells were routinely observed under microscope to check confluence, contaminations and 
morphology. Before cells reach approximately 80% confluence (% of cell coverage on the 
surface area of the culture vessel), they were subcultured.  
 
2.3 Trypsinization 
As both MG-63 and A549 grow as monolayer, in order to subculture cells, a 
proteolytic enzyme (trypsin) must be added in order to dissociate cells from the surface 
area of the culture vessel. The standard process for trypsinization for MG-63 and A549 
cells is: 1) Observation of cells under microscope to verify confluence, morphology and 
possible contaminations; 2) Removal of culture medium; 3) Wash cells with sterile 
phosphate buffer saline (PBS) pH 7.2 (Gibco); 4) Incubation of cell culture with 0.25% 
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trypsin/1mM EDTA for 5-10 min at 37 °C, until complete detachment and dissociation; 5) 
Inhibition of trypsin with the complete growth medium (2x the trypsin volume added to 
cells); 6) Cell resuspension and counting using hemocytometer; 7) After properly 
identification of the new culture flask, addition of cell suspension to a proportion of 1:9 – 
cell suspension:complete growth medium. 
 
2.4 AgNP Exposure 
1) Silver nanopowder - <100 nm particle size, 99.5% trace metals basis, obtained 
by Sigma-Aldrich®. The AgNPs are uncoated and not stabilized, according to the 
manufacture’s data. To obtain the stock solution, silver nanopowder was diluted on 
complete growth media (5% FBS) and sonicated for 1h. 
2) Spherical Silver Nanoparticle - well defined sizes particles (10nm and 
20nm), coated with PVP (Polyvinylpyrrolidone), obtained by NanoComposix - (BioPure - 
1.0 mg/ml). Stock solution was diluted in complete growth media (α-MEM or F12K) to 
obtain the desired final dilutions and sonicated for 20 minutes. 
 For both MG-63 and A549 cell lines, the procedure to exposure was mostly the 
same. Cells were seeded in multiwell plates and incubated for 24h to adhere under the 
culture conditions described above. After that period, medium was removed and replaced 
for the same amount of the desired final dilution of indicated AgNPs. The time of 
exposure was 24h and 48h in the normal culture conditions and then harvested. 
 
2.5 Charactertization of AgNPs 
The AgNPs characterization (size distribution of the AgNPs), was performed using 
Dynamic light scattering (DLS) - Malvern Zetasizer Nano ZS . This is a laser diffraction 
method, with a multiple scattering technique, to determine the particle size distribution 
of NPs. The hydrodynamic diameter (effective diameter of a particle in a liquid 
environment) of the particles was determined in suspension in the cell culture medium.  
1) Silver nanopowder – The uncoated nanoparticles were suspended on 
complete growth media (α-MEM - 5% FBS) and sonicated for 1h to form homogeneous 
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mixture and the DLS analysis was performed. The following concentrations were analyzed 
at 0 h and 24h after preparation – 10, 50, 100, 400µg/ml. 
2) Spherical Silver Nanoparticle – After preparation of nanoparticles solutions 
on complete growth media (α-MEM with 10% FBS for MG-63 cell line and F-12K with 10% 
FBS for A549 cell line) they were sonicated for 20minutes to remove aggregation. 
According to the product information, the AgNPs had a particle size of 10nm and 20nm. 
The exposure dilutions analyzed were 10, 50 and 100µg/ml after 0h and 24h preparation  
 
 
2.6 Cell proliferation and cell viability 
2.6.1 Trypan Blue Exclusion test 
On this assay, suspended cells (with growth medium - 105cells/ml) were seeded at 
24 well plates for 24h hours in order to allow adherence, at the same culture conditions. 
Afterwards, culture medium was replaced for the equivalent amount of AgNPs 
concentrations – 0, 5, 10, 50, 100, 200, 400µg/ml, diluted in complete growth medium 
and incubated for 24h and 48h. For each concentration, three replicates were used. 
Suspended cells (20µl) were transferred to eppendorfs plus 20µl of trypan blue dye 
(TC10TM, Bio-Rad, Hercules, CA). Cells were incubated for 3 to 5 min and at the end of 
incubation period, 10µl of the solution (cells and trypan blue) were added to the slide and 
the viability was counted in the automated cell counter TC10TM (Bio-Rad, Hercules, CA).  
 
2.6.2 MTT Assay 
Cell viability (MG-63 and A549) was measured by MTT assay, according to 
Lévesque et al (Levesque et al., 2008) with some modifications. One hundred µl of 
suspended cells at the concentration of 105cells/ml were seeded in 96 well plates for 24h 
for adhesion, at normal culture conditions. After 24h, the culture medium was replaced 
by 100µl of AgNP in growth medium at the following concentrations: 0, 5, 10, 20, 50, 
100µg/ml. At the control wells the culture medium was replaced for the same amount of 
fresh culture medium. 
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After AgNP exposure (24h and 48h), 50µl of MTT solution (1 mg/ml in PBS pH 7.2) 
(Sigma Aldrich) was added to each well and incubated for 4h at normal culture conditions. 
After that, the medium of each well was replaced by 150µl of Dimethyl sulfoxide (DMSO) 
and left on a shaking plate for formazan crystals solubilization, for two hours at room 
temperature protected from light. Lastly, the samples absorbance was measured by a 
microplate reader (BioTek ®– Gen5™ software) at 570 nm with blank correction. Cell 
viability was calculated using the following equation:  
Relative % Viability = A570 Sample/mean A570 Control x 100.  
 
2.7 Cell Cycle Analysis – Flow Cytometry 
Cell analysis was performed according to the method described by Bork et al (Bork 
et al., 2010) with minor modifications.  
On this assay, cells were seeded at six well plates for 24h hours in order to allow 
adherence, at the same culture conditions. Afterwards, culture medium was replaced for 
the equivalent amount of AgNPs concentrations – 0, 50, 100µg/ml, diluted in complete 
growth medium (α-MEM or F12K) and incubated for 24h and 48h. For every 
concentration, tree replicates were used and cells were daily checked under inverted 
microscope. At the end of each exposure periods, the medium was removed and cells 
were trypsinized (360µl trypsin-EDTA solution in each well). Trypsin was inhibited with 
complete growth medium and then cell suspension was transferred to microtubes. Then, 
the suspension was centrifuged at 300 g during 5 minutes and carefully ressuspended in 1 
ml of PBS pH 7.2. Finally, cells were centrifuged once more at same conditions and 
ressuspended 85% ethanol at 4 ºC for fixation and stored at -20 oC until further analysis.  
To cell cycle analyses, cells were centrifuged at 300 g during 5 minutes, 
ressuspended in 1 ml PBS pH 7.2 and vortexed for 15 seconds, and finally, filtered through 
a 55 μm nylon mesh to remove big clusters. Subsequently, 50 μg/ml of propidium iodide 
(PI) (Fluka, USA) and 50 μg/ml of RNAse were added (Sigma Aldrich, USA) to stain nuclear 
DNA and remove RNA from the samples, respectively. Samples were incubated for 20 
minutes at dark.  
 26 
 
Relative fluorescence intensity was measured in a flow cytometer (Beckman 
Coulter) equipped with an argon laser - 15 mW, 488 nm.  The fluorescence peak sample 
of G0/G1 cells adjusted to channel 200. Acquisitions were made using SYSTEM II software 
(v. 3.0, Beckman Coulter, USA). For each sample, the number of events reached 
approximately 5000. Debris and doublets were excluded by the definition of the specific 
region (Area vs. FL peak height). Cell cycle analysis was then conducted based on the 
histogram outputs (Oliveira et al., 2006). 
 
2.8 Apotosis – Annexin V Assay 
The apoptotic/necrotic cells ratio was measured by flow cytometry using the FITC 
Annexin V Apoptosis Detection Kit, from BD Pharmingen™ , by double staining with 
Annexin and PI. The double staining allows the differentiation from early-stage apoptotic 
cells (Annexin V-FITC positive/PI negative cells), from late-stage apoptotic/necrotic cells 
(Annexin V-FITC positive/PI positive), and live cells (Annexin V-FITC negative/PI negative).  
To perform this assay, 2ml of suspended cells (1x105cells/ml) were seeded in 6 
well plates. Cells were incubated for 24h to allow adherence and then exposed to the 
same amount of AgNP concentrations - 0, 50, 100µg/ml, diluted in complete growth 
medium, and incubated for 24h and 48h.  
At the end of the exposure time, cells were trypsinized and transferred to 15ml 
tubes. Afterwards, cells were centrifuged twice in cold PBS and resuspended in “1x 
binding buffer” (Detection Kit from BD Pharmingem™) (1x105cells/ml). One hundred µl of 
the sample were incubated in the dark for 10 minutes at room temperature after addition 
of 5µl annexin V-FITC and 5µl PI and later, 400 μL of “1x binding buffer” was added and 
samples analyzed by flow cytometry. The 488 nm laser was used for excitation and FITC 
was detected in FL-1 by a 525/30 BP filter while PI was detected in FL-2 by a 575/30 BP 
filter. Acquisitions were made using SYSTEM II software (v. 3.0, Beckman Coulter, USA). 
For each sample, 20 000 cells were analyzed and apoptotic (annexin V+, PI−), necrotic 
(annexin V+, PI+) and live (annexin V−, PI−) cells were expressed as percentages of the 
20000 cells. 
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2.9 Statistical Analysis  
For all experiments, at least 3 replicates, and two independent assays were 
performed. Data analysis was performed in the software SigmaPlot version 11, by one-
way ANOVA analysis of variance (One-way ANOVA) (p <0.05), followed by a Holm-Sidak 
test (p < 0.05) to evaluate the significance of differences in the parameters. When 
necessary, data were transformed to achieve normality and equality of variances. 
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3. Results  
3.1 Uncoated and Unstabilized AgNPs 
3.1.1 Characterization of AgNPs 
In order to evaluate the size distributions of the AgNPs in cell culture medium, DLS 
was used. According to product information, AgNP powder has <100nm and average size 
of 60nm. DLS measurements were obtained for the exposure concentrations. For both 
t=0 and t=24h, it is possible to see that at the higher concentration - 400µg/ml the 
uncoated NPs showed a huge aggregation behavior. For all the obtained measures (t=0 
and t=24h), an upper size distribution than 60 nm, was observed (Tables 1 and 2). 
 
Table 1 – DLS measurements of Hydrodynamic diameter of uncoated AgNPs, 0h after solutions preparations (t=0) – 
10, 50, 100 and 400µg/ml. Solutions were prepared by dilution with complete growth media - α-MEM - 5% FBS. In the 
presence of more than one peak of size distribution, the peak of higher percentage (and the respective percentage) 
was shown.  
 Average size 
(nm)a 
Hydrodynamic diameter (nm) 
10µg/ml 50µg/ml 100µg/ml 400µg/ml 
Uncoated AgNPs 60 (>%) 230.2(80%) 137.2 106.4 344.9 (81%) 
a 
According to the manufacturer Sigma-Aldrich®. 
Table 2 - DLS measurements of Hydrodynamic diameter of uncoated AgNPs, 24h after solutions preparations(t=24)  – 
10, 50, 100 and 400µg/ml. Solutions were prepared by dilution with complete growth media - α-MEM - 5% FBS. In the 
presence of more than one peak of size distribution, the peak of higher percentage (and the respective percentage) 
was shown. 
 Average size 
(nm)a 
Hydrodynamic diameter (nm) 
10µg/ml 50µg/ml 100µg/ml 400µg/ml 
Uncoated AgNPs 60(>%) 84.25 (77%) 108.1 164.5 460.5 
a 
According to the manufacturer Sigma-Aldrich®. 
 
3.1.2 Confluence and Morphology    
Cells were observed every exposure period, under the inverted microscope 
(Nikon® Eclipse TS100) (40x or 100x), to check confluence, contaminations and 
morphology. MG-63 cells had typical fibroblastic morphology and although the number of 
adherent cells was a bit higher on 50µg/ml, cell confluence was gradually lost at 200 and 
400µg/ml (Fig.1- B, C, D). 
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At the higher concentration (400 ug/ml) (Fig.1- D, Fig. 2 - C), it’s possible to see the 
agglomeration behavior of AgNPs, since their physicochemical properties are difficult to 
predict and to control.  
 
 
 
Fig. 1 - Example of MG-63 pictures after 24h of AgNPs exposure: A - Control; B - 50μg/ml; C - 
200μg/ml; D - 400μg/ml. 100X. 
Fig. 2 - Light microscopy images of MG-63 cells exposed to AgNPs for 48h: A - Control; B - 200μg/ml; C - 
400μg/ml. 40X 
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3.1.3 Cell proliferation and Viability  
3.1.3.1 Trypan Blue Exclusion Test 
Trypan Blue Exclusion Test was used to measure the viability, of MG-63 cell line, 
based on the exclusion of trypan blue by live cells. Data for 200µg/ml at 48h show a trend 
to decrease viability despite not significant (P>0.05) (Fig.3). The control values do not 
show a large variation, as we can see by the small standard deviation, which validates the 
technique and the test. Unlike the control, all the AgNPs concentrations show a high 
disparity of results being not possible to make a conclusion on the effects of uncoated 
AgNPs on MG-63 cell line viability.  
 
Fig. 3 - Effects of AgNPs on MG-63 cell viability evaluated by two independent Trypan Blue exclusion tests, for 24h and 
48h after exposure. 
 
 
3.1.3.2 MTT – Assay 
 MTT Assay was used to access the effects of AgNPs on MG-63 cell line viability.  As 
show in Fig.4, there are no significant differences in viability, between AgNP exposed cells 
and the control for both exposure periods – 24h and 48h. The large standard deviation 
bars demonstrate the high heterogeneity, and fluctuation of results, before independent 
exposures leading to inconclusive results. 
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3.2 PVP Coated AgNPs 
3.2.1 Characterization of AgNPs 
Coated AgNPs were commercially obtained, and their size is defined by 10nm and 
20nm. For both α-MEM and F-12K media (for MG-63 and A549 cells, respectively) DLS 
measurements were performed. AgNPs with 20nm diluted on α-MEM, showed a less 
tendency to aggregate at t=0 and t=24h (Table 3 and table 4) than 10nm NPs. Also, 10nm 
AgNPs at the higher concentration showed aggregates, even larger then 100nm (Tables 3 
and 4 - 100µg/ml). 
 
Table 3 - DLS measurements of Hydrodynamic diameter (nm) of 10nm and 20nm  coated AgNPs, 0h after solutions 
preparation (t=0)  – 10, 50 and 100µg/ml. Solutions were prepared by dilution with complete growth media - α-MEM 
- 10% FBS. In the presence of more than one peak of size distribution, the peak of higher percentage (and the 
respective percentage) was shown.  
 Average sizea Hydrodynamic diameter (nm) 
10µg/ml 50µg/ml 100µg/ml 
AgNPs 10nm 75.66 (62%) 53.02 136.8 
AgNPs 20nm 79.77 (83%) 51.04 49.55 
a 
According to the manufacturer NanoComposix (Biopure). 
Table 4 - DLS measurements of Hydrodynamic diameter (nm) of 10nm and 20nm  coated AgNPs, 24h after solutions 
preparation (t=24)  – 10, 50 and 100µg/ml. Solutions were prepared by dilution with complete growth media - α-
Fig. 4 - Effects of Uncoated AgNPs in MG-63 cell viability (mean ± standard deviation) for 24h and 
48h exposure, evaluated by three and two independent MTT assays. 
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MEM - 10% FBS. In the presence of more than one peak of size distribution, the peak of higher percentage (and the 
respective percentage) was shown. 
 Average sizea Hydrodynamic diameter (nm) 
10µg/ml 50µg/ml 100µg/ml 
AgNPs 10nm 70.39 (48%) 51.83 378.9 
AgNPs 20nm 46.41 44.64 44.93 
a 
According to the manufacturer NanoComposix (Biopure). 
 
For F-12K media, it is possible to see that both nanoparticles have a small 
aggregation behavior even though, also both NPs have larger aggregates than 10nm or 
20nm (table 5 and table 6).  
 
Table 5 - DLS measurements of Hydrodynamic diameter (nm) of 10nm and 20nm  coated AgNPs, 0h after solutions 
preparation (t=0)  – 10, 50 and 100µg/ml. Solutions were prepared by dilution with complete growth media – F-12K - 
10% FBS. In the presence of more than one peak of size distribution, the peak of higher percentage (and the 
respective percentage) was shown. 
 Average sizea Hydrodynamic diameter (nm) 
10µg/ml 50µg/ml 100µg/ml 
AgNPs 10nm 49.92 (55%) 75.22 (75%) 81.66 
AgNPs 20nm 78.15 (79%) 95.8 52.13 
a 
According to the manufacturer NanoComposix (Biopure). 
 
Table 6 - DLS measurements of Hydrodynamic diameter (nm) of 10nm and 20nm  coated AgNPs, 24h after solutions 
preparation (t=24)  – 10, 50 and 100µg/ml. Solutions were prepared by dilution with complete growth media – F-12K 
- 10% FBS. In the presence of more than one peak of size distribution, the peak of higher percentage (and the 
respective percentage) was shown. 
 Average sizea Hydrodynamic diameter (nm) 
10µg/ml 50µg/ml 100µg/ml 
AgNPs 10nm 17.19 (77%) 47.85 84.05 
AgNPs 20nm 79.78 (78%) 93.93 48.04 
a 
According to the manufacturer NanoComposix (Biopure). 
 
3.2.2 Confluence and Morphology 
MG-63 and A549 cells were observed every exposure period, under an inverted 
microscope (Nikon® Eclipse TS100) in a magnification of 40x or 100x, to check confluence, 
contaminations and morphology. Cell confluence was considerably less at 50µg/ml, for 
both 10nm and 20nm AgNP exposure (Fig.5 - B, C, D). 
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At 50µg/ml concentration for the size of 10nm, (Fig.5- B) it’s possible to see the 
agglomeration behavior of AgNPs. A549 cells presented typical cuboidal epithelial aspect, 
indicative of type II pulmonary morphology. After 24h exposure to 10nm and 20nm, 
confluence was less than observed at control (Fig.6 – A, B, C). Despite the visible 
agglomeration of 10nm AgNP, this treatment shows a higher confluence loss (Fig.6 - B).  
No images from 48h after exposure were showed, because there are no visible 
differences on the images, and the high scatter from AgNPs unable the visibility. 
 
 
Fig. 5 - Light microscopy images of MG-63 cells exposed to AgNPs for 24h: A - Control; B - 50μg/ml (10nm AgNP); C - 
50μg/ml (20nm AgNP). 40X 
 
 
Fig. 6 - Light microscopy images of A549 cells exposed to AgNPs for 24h: A - Control; B - 50μg/ml (10nm AgNP); C - 
50μg/ml (20nm AgNP). 40X 
 
3.2.3 Cell Viability – MTT Assay 
The MTT Assay was used in order to measure MG-63 and A549 cell lines viability, 
after 24h and 48h exposure. After 24h of exposure to AgNPs of 10nm and 20nm, a 
significant decrease on MG-63 cell viability was observed at 50µg/ml for both 10nm and 
20nm sizes (Fig.7). For NPs with 10nm, at the higher concentration (100µg/ml), it was 
possible to see a significant increase on cell viability. In addition, at 100µg/ml significant 
effects on cell viability were observed between 10nm and 20nm sizes. This test showed 
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consistent and reliable results based on the small variation of the values, as shown by 
small standard deviation.   
For the 48h exposure (Fig.8), it was possible to see the same pattern of results 
obtained for 24h. Data shows that at 50µg/ml, a significant decrease on cell viability for 
10nm AgNPs and also a significant increase on cell viability for both 10nm and 20 nm 
AgNPs at 100µg/ml). No significant differences between 10nm and 20nm AgNPs sizes 
were observed.  
 
     
Fig. 7 - Effects of Coated AgNPs – 10nm and 20nm, in MG-63 cell viability (mean ± standard deviation) for 24h exposure, 
evaluated by three independent MTT assays. Different letters represent differences between AgNPs sizes and * 
represent differences between concentrations and control. 
  
Fig. 8 - AgNPs effects in MG-63 cell viability (%) (mean ± standard deviation) to 48h time of exposure for the MTT Assay. 
* indicates differences between control and AgNP concentrations (p < 0.05). 
 35 
 
                
MTT assay for A549 cell line was performed, also for 24h and 48h exposure, in 
order to assess the effects of AgNPs on cell viability. Data show that 50µg AgNPs /ml for 
both sizes (10nm and 20nm) induced for a significant decrease on cell viability after 24h 
exposure (Fig.9). Although there is no significant difference of cell viability, between 
control and the higher concentration (100µg/ml), a significant difference between 10nm 
and 20nm AgNPs sizes response is observed. AgNPs with 10nm show a slightly decrease 
on cell viability (92%) unlike AgNP with 20nm, that show a stimulation on cell viability 
(115%).  
          
Fig. 9 - Effects of Coated AgNPs – 10nm and 20nm, in A549 cell viability (mean ± SD) for 24h exposure, evaluated by 
three independent MTT assays. Different letters represent differences between AgNPs sizes within a concentration (p < 
0.05). * indicates significant differences between AgNPs concentrations and control (p < 0.05). 
 
For 48h exposure (Fig.10), 50 μg/ml of AgNPs with 10nm induced at a decreased of 
77% on cell viability, while 100µg/ml induced a decrease of 76%. Finally, it is also 
observed a significant difference within concentrations (50µg/ml and 100µg/ml) between 
10nm and 20nm. The 20nm AgNP show a little more propensity to interfere on the redout 
of MTT assay absorbencies. 
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Fig. 10 - AgNPs effects in A549 cell viability (mean ± standard deviation) to 48h time of exposure for the MTT Assay. 
Different letters within concentrations represent differences between AgNPs sizes (p < 0.05). *indicates significant 
differences between AgNPs concentrations (p < 0.05). 
 
In order to measure the interference of AgNPs on the redout of light absorption 
for MTT assay, as possible explanation for the results obtained for MG-63 and A549 MTT 
assay at 100µg/ml, an MTT assay for AgNPs (24h) diluted on complete medium but with 
no cells was performed. As show in Fig.11, after 24h there is a significant increase on 
absorbance for 50µg/ml and 100µg/ml. As for the 20 nm AgNP, to both 50μg/ml and 
100μg/m the absorbance increased 54% and the 145% respectively. Within 
concentrations, no significant variations were detected between 10nm and 20nm AgNPs.  
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Fig. 11 - Absorbance of MTT assay (mean ± standard deviation) for Coated AgNPs 10nm and 20 nm after 24h, on 
complete medium with no cells. Different letters represent differences between AgNPs concentrations (p < 0.05). 
 
3.2.4 Cell cycle Analysis – Flow cytometry 
After 24h exposure, cells (MG-63 and A549) were collected to perform cell cycle 
analysis and the global cell cycle stages are presented in Figs.12 and 13. In MG-63 cells, 
for both 10nm and 20nm AgNP there was a significant decrease of Go/G1 cell percentage, 
with increase in AgNP concentration. For the 100µg/ml concentration, results were 
significantly different (Fig.12). Also, for both 10nm and 20nm it is possible to see an 
accumulation of cells on G2 phase. 
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Fig. 12 - Cell cycle results of MG-63 AgNP exposure after 24 h. The given values are the mean % of cell population (± 
standard deviation) along cell cycle stages of at least 3 replicates. * indicates differences between AgNP size’s within a 
concentration at p <0.05. 
 
For the A549 cell line, the effects of AgNPs on cell cycle were more prominent 
than for the MG-63 cell line, and large differences were observed. As shown in Fig.13, 
there is a significant decrease on percentage of G0/G1 cell population and also a 
significant increase in the percentage of cells in G2 under AgNp exposure, for both 10nm 
and 20nm.  
 
Fig. 13 - Cell cycle results of A549 AgNP exposure after 24 h. The given values are the mean % of cell population (± 
standard deviation) along cell cycle stages of at least 3 replicates. *indicates differences betwee AgNP size’s within a 
concentration at p <0.05 
 39 
 
3.2.5 Apoptosis –Annexin V Assay 
Annexin V Assay was used in order to measure the apoptotic/necrotic cells ratio, 
by flow cytometry using double staining with Annexin V-FITC and PI. The double staining, 
allows the differentiation from early-stage apoptotic cells, late-stage, apoptotic/necrotic 
and also from live cells. Both MG-63 and A549 cell lines were exposed, to the 
concentration of 50µg AgNPs / ml, of both 10nm and 20nm sizes, for 24h and 48h. As 
show in Figs.14 and 15, there are no significant differences in the percentage of cells 
under apoptosis for the AgNP concentration of 50µg/ml for both 10nm and 20nm sizes, 
comparatively to the control in both exposure periods – 24h and 48h. 
 
Fig. 14 - Annexin V-FITC assay for apoptosis assessment of MG-63 cell line. Results for 24h exposures to 10nm and 20nm 
AgNPs with 3 replicates. ± SD. 
 
 
Fig. 15 - Annexin V-FITC assay for apoptosis assessment of MG-63 cell line. Results for 48h exposures to 10nm and 20nm 
AgNPs with 3 replicates. ± SD. * p<0.05. 
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For A549 cell line (24h exposure), the results (Fig.16) show a significant decrease 
on the amount of viable cells, for the 10 nm AgNPs in 50µg/ml, and a significant increase 
on the percentage of late-apoptotic cell (Fig.16 – 10nm). No significant differences were 
observed, for 24h exposure, between control and 50µg/ml - 20nm AgNPs. 
 
 
Fig. 16 - Annexin V-FITC assay for apoptosis assessment of A549 cell line. Results for 24h exposure to, 10nm and 20nm 
AgNPs, with 3 replicates. *indicates differences between control and AgNP concentrations at p <0.05. 
 
The 48 hours assay for A549 cell line, shows at 50 µg/ml, a significant increase the 
percentage of cells in early and late apoptosis and a decreased the percentage of live cells 
for both 10nm and 20nm sizes (Fig. 17). 
 
 
Fig. 17 - Annexin V-FITC assay for apoptosis assessment of A549 cell line. Results for 48h exposure to 10nm and 20nm 
AgNPs with 3 replicates. * indicates differences between control and AgNP concentrations at p <0.05. 
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4. Discussion 
 
NPs technology is an emerging field, with multiple potentialities and applications. 
However, and due to the particular characteristics of NPs, comparatively to their 
individual components, NPs may present also different toxicity profiles. Despite NPs have 
always been present in the environment, the concern on their toxicity has only emerged 
during the last decade. A huge increase of NPs industry, and multiple applications has 
been noticed (Donaldson et al., 2006; Lewinski et al., 2008; Medina et al., 2007), but the 
potential for adverse health effects, due to prolonged exposure (through various routes 
such as skin, respiratory and gastrointestinal tract and blood) at a range of concentration 
levels, in humans and the environment has not yet been established (Beer et al., 2012; 
Nagai et al., 2001; Remédios et al., 2012). 
The small size/large surface area, and surface properties, are fundamental 
characteristics of NPs that affect their behavior (adhesion, aggregation, transport, and 
bioavailability), becoming difficult to predict or asses their toxic effects.  
At the first part of this study, uncoated AgNPs with <100nm size (peak size – 
60nm) were used. Uncoated AgNPs are more exposed to the surrounding media, and 
more likely to interact with medium components, leading to higher variations in particles 
size and stabilization, and this will affect the NPs behavior, being more difficult to predict 
their effect. (Allen et al., 2010; El Badawy et al., 2012). The used mediums (α-MEM and F-
12K) are rich in salts, nutrients and most important, electrolytes and chlorides. These 
components interfere with, size and stability of NPs, and they may react with silver from 
the AgNPs and precipitate (silver chloride) or modify the surface charge, so AgNPs may 
aggregate or even becoming not available at the solution. Furthermore, uncoated metal 
NPs have typically lyophobic behavior (no affinity for the dispersion medium), and they 
tend to form large aggregates (that cannot enter the cell), decreasing their bioavailability 
(Verma et al., 2008). The data obtained on this work, from microscopic observation, and 
DLS measurements, using uncoated/uncalibrated AgNPs (<100nm), support this facts and 
it is supported by other authors (Allen et al., 2010; El Badawy et al., 2012; Verma et al., 
2008). Both Trypan blue and MTT assay show high heterogeneity and disparity of results, 
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being impossible to achieve a conclusion. The results obtained by these viability tests, 
could be explained by the formation of the aggregates. Altogether, assessing as much as 
possible, the size and chemical speciation of the AgNPs, throughout a particular 
experiment, with an emphasis on characterization in the media of interest, is imperative.  
The evaluation of their toxicological effects, without stabilization and 
normalization, is complex and leads to inconclusive results being inadequate and 
particularly burdensome to assess AgNP cytotoxicity in vitro. 
Coated AgNPs tend to be easier to work with, and less reactive towards 
surrounding components. These AgNPs, have a great importance, since engineered and 
manufactured NPs (generally coated) might be released on the environment, at a huge 
scale, by several sources (Flahaut, 2010; Klaine et al., 2008; Ray et al., 2009; Remédios et 
al., 2012).  Two well defined sizes of AgNPs were used, in order to detect some changes 
on NPs behavior, and effects on the cellular viability. Both MG-63 and A549 cell’s viability 
data, shows lower standard deviation error than those obtained by uncoated NPs 
exposure, suggesting more reliable results. Also, for both MG-63 and A549 cell lines it is 
possible to see a significant decrease in cell viability at the 50µg/ml concentration for the 
two AgNPs sizes (10nm and 20nm). Other researchers also reported that cell viability was 
markedly reduced as a function of both culture time and AgNP concentration, in human 
IMR-90 and U251 cells and in mouse embryonic stem cells (Ahamed et al., 2008; AshaRani 
et al., 2009b). Although MG-63 data shows a decrease on viability, at the 50µg/ml, an 
increase on cell viability, at the higher concentration (100µg/ml) is observed for both 
sizes, especially for 10nm. This increase on cell viability may be justified by the fact that 
AgNPs aggregation should increase with increasing concentration, reducing the surface 
area available to which the cells are exposed  (El Badawy et al., 2012). DLS results for both 
AgNPs suspended on α-MEM, for this same concentration (100µg/ml) may explain MTT 
results, showing that very large aggregates are obtained, especially for the 10nm AgNPs.  
Another explanation, may relay on the fact that NPs interfere with classic cytotoxicity 
assays (such as MTT) in a highly concentration-, particle- and assay-speciﬁc manner (Kroll 
et al., 2009; Kroll et al., 2012; Rabolli et al., 2010). Their intrinsic optical absorbance, and 
adsorption of assay reagents or reporter dyes might interfere with assay components, 
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resulting in an over/underestimation of their toxicity (Kroll et al., 2012; Rabolli et al., 
2010; Sabatini et al., 2007).  In particular, we found that AgNPs have a concentration-
dependent increase in MTT-formazan light absorption and a concentration-dependent 
size of aggregates. At the higher concentration - 100µg/ml, as expected, a significant 
increase on the values of absorbance was observed and may be due to light scattering 
effect or/and adsorb MTT-formazan crystals, thereby preventing solubilizations. This high 
absorbance is supported by other authors, and it is conclusive that leads to a false-
negative, underestimating AgNPs toxicity (Kroll et al., 2012; Sabatini et al., 2007; Samberg 
et al., 2010). 
In order to examine whether the observed inhibition of cell growth involved 
changes in the cell cycle phase distribution, the concentrations of 50µg/ml  and 
100µg/ml, were chosen to assess the effects of AgNPs on MG-63 and A549 cell lines. For 
the concentration of 50µg/ml a significant decrease on cell viability was observed, while 
for the concentration of 100µg/ml, a putative false-negative in the MG-63 cell line 
occurred. At the present work, under the 100µg/ml, MG-63 cell population showed a 
significant decrease in the percentage of cells at Go/G1, along with concentration 
increase. Also, with the increase of AgNP dose, the percentage of G2 population 
increased.  The 100µg/ml concentration showed disturbances on MG-63 cell cycle and 
also showed a decrease on the number of events counted by flow cytometry. This result 
helped to validate the hypothesis that a false-negative was obtained on the MTT assay for 
100µg/ml - the toxicity for this concentration was underestimated. For the A549 cell line, 
differences between control and AgNPs concentrations were obtained with lower 
concentrations (than with MG-63) in the cell cycle data, suggesting that this cell line it is 
more sensitive. The same trend of response of MG-63 (100µg/ml) was obtained for A549 
(50µg/ml), where a decrease in the percentage of cells in Go/G1 and an accumulation in 
G2-phase occurred. This result is in agreement with previous findings showing that an 
increase in the number of cells in G2 phase is related to apoptosis (Lee et al., 2011; Lee et 
al., 2009; Zhang et al., 2009). When G2/M checkpoint is activated, cells have chance to 
repair DNA damages preventing them from entering mitosis or cells may enter in 
apoptosis.  
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Additionally, our data indicates that AgNPs also increases cell death by apoptosis, 
according with the trend to cell cycle arrest at G2 checkpoint. The data from Annexin V 
assay shown that, already at 24 hours (for A549 cell line), AgNP induced apoptosis. After 
24h, exposure to 10nm AgNP induced a decrease on viable cells, and an increase on late 
apoptotic cells. According to other studies, A549 cells have a constitutively high 
expression of the heme oxygenase-1, which might render them less susceptible to ROS-
induced cell death - early apoptosis (Foldbjerg et al., 2011; Kweon et al., 2006). For 20nm, 
there were no significant differences between control and 50µg/ml. This may be 
explained by the fact that exist a size-dependent cellular uptake of SNPs (Liu et al., 
2010b). For 48h period, AgNPs (10nm and 20nm) at 50µg/ml, an increase on the number 
of cells in early and late apoptosis and a decrease in live cell number was found. This 
increase on apoptotic cells is supported by previous works (Beer et al., 2012; Foldbjerg et 
al., 2011; Lee et al., 2011; Piao et al., 2011).  Although, there is a difference on the type of 
apoptotic response, – 10nm show higher amount of early apoptotic cells, and 20 nm show 
a higher amount of late apoptotic cells. A study on DNA fragmentation it is needed to be 
carried out, since DNA fragmentation is a characteristic from late apoptosis (Foldbjerg et 
al., 2011). MG-63 cell line showed no differences on live/apoptotic cells, as well as, no 
significant difference on cell cycle was observed for the same concentration (50µg/ml). 
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5. Conclusion and Future Perspectives 
In conclusion, these results suggest that uncoated/uncalibrated AgNPs lead to 
inconclusive results, being inadequate and particularly burdensome to assess AgNP 
cytotoxicity in vitro. Although the high reliability of results obtained with coated AgNPs, is 
still required a careful characterization of particle properties, and an extensive validation 
of assay systems. Commercial information about NPs is not always the same after they 
are put in solution and after interaction with surrounding medium. Nps characterization it 
is a crucial step to understand some of their effects, for both in vitro assays and 
environmental assessment. 
 AgNPs can decrease viability of MG-63 and A549 cell line. Higher doses may even 
interfere on cell cycle, promoting a G2/M phase arrest along with an increase in apoptosis. 
A549 cell line appears to be more sensitive to AgNPs than MG-63 cell line, since higher 
doses are needed for MG-63 to show the same effects.  
Therefore, in future work, another trial of cell cycle assay could be performed and 
DNA damage (comet assay) and oxidative stress (as ROS) should be evaluated in order to 
understand the pathway that cells go through. Also a validation of assays, especially MTT 
should be done.  
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